IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
0.1300
0.00 (0.00%)
At close: Aug 13, 2026, 4:00 PM EDT
0.1270
-0.0030 (-2.31%)
Pre-market: Aug 14, 2026, 4:22 AM EDT
IM Cannabis Revenue
IM Cannabis had revenue of 7.59M CAD in the quarter ending June 30, 2026, a decrease of -40.23%. This brings the company's revenue in the last twelve months to 45.80M, down -12.61% year-over-year. In the year 2025, IM Cannabis had annual revenue of 54.73M with 1.30% growth.
Revenue (ttm)
45.80M CAD
Revenue Growth
-12.61%
P/S Ratio
0.02
Revenue / Employee
1,040,977 CAD
Employees
44
Market Cap
809.03K USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 54.73M | 700.00K | 1.30% |
| Dec 31, 2024 | 54.03M | 5.23M | 10.71% |
| Dec 31, 2023 | 48.80M | -5.53M | -10.18% |
| Dec 31, 2022 | 54.34M | 20.28M | 59.56% |
| Dec 31, 2021 | 34.05M | 18.16M | 114.30% |
| Dec 31, 2020 | 15.89M | 6.82M | 75.12% |
| Dec 31, 2019 | 9.07M | 3.88M | 74.60% |
| Dec 31, 2018 | 5.20M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sunshine Biopharma | 35.49M |
| Sonoma Pharmaceuticals | 21.92M |
| cbdMD | 19.98M |
| Universe Pharmaceuticals INC | 17.74M |
| InMed Pharmaceuticals | 4.94M |
| China SXT Pharmaceuticals | 1.14M |
| Gelteq | 314.70K |
| RedHill Biopharma | 286.00K |
IMCC News
- 11 hours ago - IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results - PRNewsWire
- 6 days ago - IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing - PRNewsWire
- 17 days ago - IM Cannabis Provides Corporate Update - PRNewsWire
- 6 weeks ago - IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing - PRNewsWire
- 2 months ago - IM Cannabis signs LoI to sell European activities - TheFly
- 2 months ago - IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million - PRNewsWire
- 2 months ago - IM Cannabis Announces Form F-3 Resale Registration Statement Filing - PRNewsWire
- 2 months ago - IM Cannabis registers to sell 17.28M common shares for holders - TheFly